Report cover image

Global Systemic Lupus Erythematosus Treatment Market Size Study, by Treatment Type (NSAIDs, Antimalarial Drugs, Corticosteroids, Immunosuppressants, Biologics), by Route of Administration (Oral, Intravenous, Subcutaneous), by End User (Hospitals, Clinics,

Publisher Bizwit Research & Consulting
Published Oct 08, 2024
Length 285 Pages
SKU # BIZW19221512

Description

Global Systemic Lupus Erythematosus Treatment Market Size Study, by Treatment Type (NSAIDs, Antimalarial Drugs, Corticosteroids, Immunosuppressants, Biologics), by Route of Administration (Oral, Intravenous, Subcutaneous), by End User (Hospitals, Clinics, Homecare, Specialty Centers) and Regional Forecasts 2022-2032


The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast period 2024-2032. Systemic Lupus Erythematosus (SLE) treatment focuses on managing symptoms and reducing inflammation to prevent disease flares and organ damage. It typically involves a combination of medications and lifestyle adjustments. Common treatments include nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation, corticosteroids to control severe symptoms, and antimalarials like hydroxychloroquine to manage skin and joint symptoms. Immunosuppressive drugs may be used to control more serious manifestations affecting organs. Additionally, personalized approaches often incorporate lifestyle modifications, such as stress management and sun protection, to help mitigate symptoms and improve quality of life. Regular monitoring and adjustments are crucial for effective management. The rising prevalence of SLE, increasing awareness about the disease, advancements in treatment options, and growing healthcare expenditure are key factors driving the market growth.

Technological advancements and research initiatives are leading to the development of innovative therapies and biologics, further fueling market growth. The introduction of biologics has revolutionized the treatment landscape for SLE, offering targeted and effective treatment options. Furthermore, increasing investments in R&D activities for the development of novel therapeutics and the growing pipeline of SLE drugs are expected to boost market growth during the forecast period. However, stringent regulatory policies and the high cost of biologic therapies pose challenges to market growth. The side effects associated with current SLE treatments, such as immunosuppressants and corticosteroids, also limit their long-term use and highlight the need for safer and more effective treatment options. In addition, the market presents lucrative opportunities, especially in emerging economies with improving healthcare infrastructure and rising awareness about autoimmune diseases.

The key region in the Global Systemic Lupus Erythematosus Treatment Market includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2023, North America dominates the market in terms of revenue due to high healthcare expenditure, the presence of key market players, and advanced healthcare infrastructure. Europe is the second-largest market, driven by increasing research activities and measures taken for SLE management. The Asia-Pacific region is expected to be the fastest-growing market due to increasing awareness, a rising population affected by SLE, and improving healthcare facilities. The Middle East & Africa region holds the smallest market share due to limited healthcare infrastructure and lack of awareness about SLE treatment options.



Major market players included in this report are:

Sanofi

Hoffmann-La Roche Ltd

Novartis AG

Pfizer Inc.

GlaxoSmithKline plc

AstraZeneca

Eli Lilly and Company

Bristol-Myers Squibb Company

Amgen Inc.

Anthera

Johnson & Johnson Services, Inc.



The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

NSAIDs

Antimalarial Drugs

Corticosteroids

Immunosuppressants

Biologics



By Route of Administration:

Oral

Intravenous

Subcutaneous



By End User:

Hospitals

Clinics

Homecare

Specialty Centers



By Region:

North America

U.S.

Canada



Europe

UK

Germany

France

Spain

Italy

ROE



Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC



Latin America

Brazil

Mexico

Rest of Latin America



Middle East & Africa

Saudi Arabia

South Africa

RoMEA



Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032



Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues and regional level analysis for each market segment.

Detailed analysis of geographical landscape with Country level analysis of major regions.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Global Systemic Lupus Erythematosus Treatment Market Executive Summary
1.1. Global Systemic Lupus Erythematosus Treatment Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Treatment Type
1.3.2. By Route of Administration
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Systemic Lupus Erythematosus Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Systemic Lupus Erythematosus Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Increasing awareness regarding systemic lupus erythematosus
3.2. Market Challenges
3.2.1. Stringent regulatory policies
3.2.2. Side effects of medications
3.3. Market Opportunities
3.3.1. Increasing investment in pharmaceutical research activities
3.3.2. Expanding use of biologics and innovative therapies
Chapter 4. Global Systemic Lupus Erythematosus Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Systemic Lupus Erythematosus Treatment Market Size & Forecasts by Treatment Type 2022-2032
5.1. Segment Dashboard
5.2. Global Systemic Lupus Erythematosus Treatment Market: Treatment Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. NSAIDs
5.2.2. Antimalarial Drugs
5.2.3. Corticosteroids
5.2.4. Immunosuppressants
5.2.5. Biologics
Chapter 6. Global Systemic Lupus Erythematosus Treatment Market Size & Forecasts by Route of Administration 2022-2032
6.1. Segment Dashboard
6.2. Global Systemic Lupus Erythematosus Treatment Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Oral
6.2.2. Intravenous
6.2.3. Subcutaneous
Chapter 7. Global Systemic Lupus Erythematosus Treatment Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Systemic Lupus Erythematosus Treatment Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals
7.2.2. Clinics
7.2.3. Homecare
7.2.4. Specialty Centers
Chapter 8. Global Systemic Lupus Erythematosus Treatment Market Size & Forecasts by Region 2022-2032
8.1. Americas Systemic Lupus Erythematosus Treatment Market
8.1.1. U.S. Systemic Lupus Erythematosus Treatment Market
8.1.1.1. Treatment Type breakdown size & forecasts, 2022-2032
8.1.1.2. Route of Administration breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Systemic Lupus Erythematosus Treatment Market
8.2. Europe Systemic Lupus Erythematosus Treatment Market
8.2.1. U.K. Systemic Lupus Erythematosus Treatment Market
8.2.2. Germany Systemic Lupus Erythematosus Treatment Market
8.2.3. France Systemic Lupus Erythematosus Treatment Market
8.2.4. Spain Systemic Lupus Erythematosus Treatment Market
8.2.5. Italy Systemic Lupus Erythematosus Treatment Market
8.2.6. Rest of Europe Systemic Lupus Erythematosus Treatment Market
8.3. Asia-Pacific Systemic Lupus Erythematosus Treatment Market
8.3.1. China Systemic Lupus Erythematosus Treatment Market
8.3.2. India Systemic Lupus Erythematosus Treatment Market
8.3.3. Japan Systemic Lupus Erythematosus Treatment Market
8.3.4. Australia Systemic Lupus Erythematosus Treatment Market
8.3.5. South Korea Systemic Lupus Erythematosus Treatment Market
8.3.6. Rest of Asia Pacific Systemic Lupus Erythematosus Treatment Market
8.4. Latin America Systemic Lupus Erythematosus Treatment Market
8.4.1. Brazil Systemic Lupus Erythematosus Treatment Market
8.4.2. Mexico Systemic Lupus Erythematosus Treatment Market
8.4.3. Rest of Latin America Systemic Lupus Erythematosus Treatment Market
8.5. Middle East & Africa Systemic Lupus Erythematosus Treatment Market
8.5.1. Saudi Arabia Systemic Lupus Erythematosus Treatment Market
8.5.2. South Africa Systemic Lupus Erythematosus Treatment Market
8.5.3. Rest of Middle East & Africa Systemic Lupus Erythematosus Treatment Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Sanofi
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Hoffmann-La Roche Ltd
9.3.3. Novartis AG
9.3.4. Pfizer Inc.
9.3.5. GlaxoSmithKline plc
9.3.6. AstraZeneca
9.3.7. Eli Lilly and Company
9.3.8. Bristol-Myers Squibb Company
9.3.9. Amgen Inc.
9.3.10. Anthera
9.3.11. Johnson & Johnson Services, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research AttributesList of Tables
TABLE 1. Global Systemic Lupus Erythematosus Treatment market, report scope
TABLE 2. Global Systemic Lupus Erythematosus Treatment market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Systemic Lupus Erythematosus Treatment market estimates & forecasts by Treatment Type 2022-2032 (USD Billion)
TABLE 4. Global Systemic Lupus Erythematosus Treatment market estimates & forecasts by Route of Administration 2022-2032 (USD Billion)
TABLE 5. Global Systemic Lupus Erythematosus Treatment market estimates & forecasts by End User 2022-2032 (USD Billion)
TABLE 6. Global Systemic Lupus Erythematosus Treatment market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Systemic Lupus Erythematosus Treatment market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Systemic Lupus Erythematosus Treatment market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Systemic Lupus Erythematosus Treatment market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Systemic Lupus Erythematosus Treatment market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Systemic Lupus Erythematosus Treatment market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Systemic Lupus Erythematosus Treatment market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Systemic Lupus Erythematosus Treatment market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Systemic Lupus Erythematosus Treatment market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Systemic Lupus Erythematosus Treatment market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Systemic Lupus Erythematosus Treatment market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Systemic Lupus Erythematosus Treatment market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Systemic Lupus Erythematosus Treatment market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Systemic Lupus Erythematosus Treatment market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Systemic Lupus Erythematosus Treatment market estimates & forecasts by segment 2022-2032 (USD Billion)
.....
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.List of Figures
FIGURE 1. Global Systemic Lupus Erythematosus Treatment market, research methodology
FIGURE 2. Global Systemic Lupus Erythematosus Treatment market, market estimation techniques
FIGURE 3. Global market size estimates & forecast methods
FIGURE 4. Global Systemic Lupus Erythematosus Treatment market, key trends 2023
FIGURE 5. Global Systemic Lupus Erythematosus Treatment market, growth prospects 2022-2032
FIGURE 6. Global Systemic Lupus Erythematosus Treatment market, porters 5 force model
FIGURE 7. Global Systemic Lupus Erythematosus Treatment market, PESTEL analysis
FIGURE 8. Global Systemic Lupus Erythematosus Treatment market, value chain analysis
FIGURE 9. Global Systemic Lupus Erythematosus Treatment market by segment, 2022 & 2032 (USD Billion)
FIGURE 10. Global Systemic Lupus Erythematosus Treatment market by segment, 2022 & 2032 (USD Billion)
FIGURE 11. Global Systemic Lupus Erythematosus Treatment market by segment, 2022 & 2032 (USD Billion)
FIGURE 12. Global Systemic Lupus Erythematosus Treatment market by segment, 2022 & 2032 (USD Billion)
FIGURE 13. Global Systemic Lupus Erythematosus Treatment market by segment, 2022 & 2032 (USD Billion)
FIGURE 14. Global Systemic Lupus Erythematosus Treatment market, regional snapshot 2022 & 2032
FIGURE 15. North America Systemic Lupus Erythematosus Treatment market 2022 & 2032 (USD Billion)
FIGURE 16. Europe Systemic Lupus Erythematosus Treatment market 2022 & 2032 (USD Billion)
FIGURE 17. Asia pacific Systemic Lupus Erythematosus Treatment market 2022 & 2032 (USD Billion)
FIGURE 18. Latin America Systemic Lupus Erythematosus Treatment market 2022 & 2032 (USD Billion)
FIGURE 19. Middle East & Africa Systemic Lupus Erythematosus Treatment market 2022 & 2032 (USD Billion)
FIGURE 20. Global Systemic Lupus Erythematosus Treatment market, company market share analysis (2023)
.....
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us